Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP Chemotherapy in Poor Prognosis Male Germ Cell Tumors

NCT00301782 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00301782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00301782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP Chemotherapy in Poor Prognosis Male Germ Cell Tumors
Lead sponsor
Medical Research Council
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2010
Enrollment
88 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

extragonadal germ cell tumor, teratoma, testicular germ cell tumor